| 摘要 |
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases. |
| 申请人 |
AMIRA PHARMACEUTICALS, INC.;HUTCHINSON, JOHN, H.;PRASIT, PETPIBOON, PEPPI;MORAN, MARK;EVANS, JILLIAN, F.;LI, YIWEI;WANG, BOWEI;ARRUDA, JEANNIE, M.;STOCK, NICHOLAS, SIMON |
发明人 |
HUTCHINSON, JOHN, H.;PRASIT, PETPIBOON, PEPPI;MORAN, MARK;EVANS, JILLIAN, F.;LI, YIWEI;WANG, BOWEI;ARRUDA, JEANNIE, M.;STOCK, NICHOLAS, SIMON |
